WIBP‐CorV – Sinopharm‐Wuhan vs placebo
Serious adverse eventsi
WIBP‐CorV – Sinopharm‐Wuhan showed no clear difference in serious adverse eventsi compared with placebo (low certainty).
1 finding from 1 review
- RR 0.83 [0.6, 1.15]2 studies · 27029 participantsLow